Join our Community
Support ToI and remove all ads
Learn more
×

Ugur Sahin

Ugur Sahin, co-founder of the Mainz-based coronavirus vaccine developer BioNTech, listens during an Axel Springer Award ceremony, March 18, 2021.(Bernd von Jutrczenka/dpa via AP, Pool)
February 17, 2022, 5:00 pm
World ‘better prepared’ to deal with new COVID variants, BioNTech CEO says
New COVID variants inevitable, Ugur Sahin warns, but the world is ‘learning more’ and getting a ‘better understanding on how to deal with the virus’
By AFP
A woman is vaccinated against COVID-19 at the Hillbrow Clinic in Johannesburg, South Africa, Dec. 6, 2021 (AP Photo/ Shiraaz Mohamed, File)
December 9, 2021, 10:14 am
Vaccine makers race to update COVID shots for Omicron strain, just in case
Experts doubt current vaccines will become useless in face of new variant, but virus is currently moving faster than science
By LAURAN NEERGAARD
Ugur Sahin, co-founder of the Mainz-based coronavirus vaccine developer BioNTech, listens during an Axel Springer Award ceremony, March 18, 2021.(Bernd von Jutrczenka/dpa via AP, Pool)
April 28, 2021, 6:07 pm
BioNTech chief ‘confident’ Pfizer vaccine works against Indian virus strain
Ugur Sahin, co-founder of company that jointly developed leading COVID-19 inoculation, says shots have proved effective against other similar mutations
By AFP and ToI Staff
Doses of the Pfizer-Biontech COVID-19 coronavirus vaccine at a vaccination center in Magdeburg, eastern Germany, on December 27, 2020. (Ronny Hartmann / POOL / AFP)
December 27, 2020, 11:54 am
How BioNTech-Pfizer won the great global coronavirus vaccine race
As the German biotechnology firm worked on a shot to defeat virus, other companies around the country already began organizing the infrastructure needed to deliver it to billions
By Hui Min NEO, Yannick Pasquet, Michelle Fitzpatrick and Yann Schreiber
Ugur Sahin, CEO of Biontech, gestures during an interview in Mainz, Germany, November 27, 2019. (Andreas Arnold/dpa via AP)
December 22, 2020, 12:32 pm
BioNTech CEO confident vaccine developed with Pfizer works on UK virus variant
Head of German pharmaceutical company says it will take another two weeks to get enough data to know for sure if inoculation effective against more contagious mutated strain
By AP and ToI Staff
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.